Trials / Unknown
UnknownNCT05909020
EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem
EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem to Redesign the Suspected Head and Neck Cancer Referral Pathway (Phase 1)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 165 (estimated)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Can a patient-reported symptom-based risk stratification system improve the suspected head and neck cancer (HNC) pathway? Our methodology includes six interlinked work packages to deliver our aim, with EVEREST-HN 1 encompassing the first of these and seeking to optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system.
Detailed description
The EVEREST-HN pathway should be based on a comprehensive understanding of existing HNC diagnostic pathways and what patients and clinicians value in these. The language used within the EVEREST pathway needs to be accessible and optimal to elicit appropriate information.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention. | No intervention. |
Timeline
- Start date
- 2023-03-17
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
- First posted
- 2023-06-18
- Last updated
- 2023-10-03
Locations
4 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05909020. Inclusion in this directory is not an endorsement.